These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6897647)

  • 21. Response of a high-glucuronidase human tumour xenograft to aniline mustard.
    Warenius HM; Workman P; Bleehen NM
    Br J Cancer; 1982 Jan; 45(1):27-34. PubMed ID: 7059462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of thaliblastine on transplantable tumours in mice.
    Mircheva J; Stoychkov J
    Biomedicine; 1976 Sep; 25(8):280-1. PubMed ID: 137002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The synergic action of the bovine growth hormone with some cytostatic drugs in the experimental therapy of Ehrlich and NK-Ly ascites tumors in mice.
    Baranowicz JW
    Neoplasma; 1973; 20(1):47-50. PubMed ID: 4121992
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative studies of the cytostatic effect of a new N-Lost derivative "IMET 3393" and Endoxan in 3 experimental mice tumors (Ehrlich ascites carcinoma, sarcoma 180 solid, leukemia LAJ I)].
    Schnabel R; Jungstand W; Gutsche W; Grimm H; Fritsch S
    Acta Biol Med Ger; 1967; 19(4):543-58. PubMed ID: 5596676
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of the cytotoxic effect of the monoterpene indole alkaloid echitamine in-vitro and in tumour-bearing mice.
    Jagetia GC; Baliga MS; Venkatesh P; Ulloor JN; Mantena SK; Genebriera J; Mathuram V
    J Pharm Pharmacol; 2005 Sep; 57(9):1213-9. PubMed ID: 16105243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [In vitro and in vivo experiments on multiple-step cancer therapy; attack induction by alkylating cytostatics].
    von Ardenne M; Chaplain RA; Reitnauer PG
    Dtsch Gesundheitsw; 1969 Sep; 24(38):1781-7. PubMed ID: 5376244
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cross resistance studies in degranol resistant NK-ly ascites tumors].
    Gáti E
    Z Krebsforsch; 1966; 68(2):184-9. PubMed ID: 4228637
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug resistance study in a mixed nitrogen mustard-sensitive-resistant tumour.
    Ujházy V
    Neoplasma; 1969; 16(4):467-8. PubMed ID: 5344233
    [No Abstract]   [Full Text] [Related]  

  • 29. 3-N,N-bis(2-chloroethylamino)p-toluic acid, a new cytostatic drug active in cancer.
    Dobre V; Maltezeanu G
    Cancer Chemother Rep; 1970 Oct; 54(5):319-23. PubMed ID: 5514620
    [No Abstract]   [Full Text] [Related]  

  • 30. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell activity and anti-tumour effects of dehydrocrotonin and its synthetic derivatives.
    Melo PS; Justo GZ; Durán N; Haun M
    Eur J Pharmacol; 2004 Mar; 487(1-3):47-54. PubMed ID: 15033375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carcinostatic activity of methylglyoxal and related substances in tumour-bearing mice.
    Conroy PJ
    Ciba Found Symp; 1978; (67):271-300. PubMed ID: 159813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host resistance against tumor and its synergic effect with cancer chemotherapy.
    Sato R
    Gan; 1967 Jun; 58(3):211-20. PubMed ID: 6081225
    [No Abstract]   [Full Text] [Related]  

  • 34. [STUDIES ON THE EFFECT OF NEW NITROGEN MUSTARD ANALOGES ON NK/LY TRANSPLANTABLE TUMORS].
    KURNATOWSKI A
    Pr Lodz Tow Nauk IV; 1964; 58():1-44. PubMed ID: 14218659
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic effects of irinotecan and flavonoids on Ehrlich ascites tumour-bearing mice.
    Knežević AH; Dikić D; Lisičić D; Kopjar N; Oršolić N; Karabeg S; Benković V
    Basic Clin Pharmacol Toxicol; 2011 Nov; 109(5):343-9. PubMed ID: 21624058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitrogen mustard interference with potassium transport systems in Ehrlich ascites tumor cells.
    Doppler W; Hofmann J; Oberhuber H; Maly K; Grunicke H
    J Cancer Res Clin Oncol; 1985; 110(1):35-41. PubMed ID: 4019567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
    Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
    Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antitumour activity of a series of benzothiophenes.
    Hellmann K; Marshall PG; Stayt S
    Biochem Pharmacol; 1967 Apr; 16(4):681-7. PubMed ID: 6033788
    [No Abstract]   [Full Text] [Related]  

  • 39. THE EFFECT OF NITROGEN MUSTARD ON THE LIFE CYCLE OF EHRLICH ASCITES TUMOR CELLS IN VIVO.
    LAYDE JP; BASERGA R
    Br J Cancer; 1964 Mar; 18(1):150-8. PubMed ID: 14154230
    [No Abstract]   [Full Text] [Related]  

  • 40. Cytotoxicity of aniline mustard glucuronide alone or in a combination with glucose in Walker cells in culture and sarcoma-180 tumour bearing animals.
    Deliconstantinos G; Ramantanis G; Todorou DK
    Biomed Pharmacother; 1983; 37(7):339-43. PubMed ID: 6667340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.